- Report
- January 2026
- 220 Pages
Global
From €2210EUR$2,500USD£1,915GBP
- Report
- January 2026
- 100 Pages
Global
From €2210EUR$2,500USD£1,915GBP
- Report
- January 2026
- 180 Pages
Global
From €2210EUR$2,500USD£1,915GBP
- Report
- November 2025
- 200 Pages
Global
From €7027EUR$7,950USD£6,089GBP
- Report
- November 2025
- 200 Pages
Global
From €7027EUR$7,950USD£6,089GBP
- Report
- November 2025
- 200 Pages
Global
From €7027EUR$7,950USD£6,089GBP
- Report
- November 2025
- 200 Pages
Global
From €7027EUR$7,950USD£6,089GBP
- Report
- November 2025
- 200 Pages
Global
From €7027EUR$7,950USD£6,089GBP
- Report
- November 2025
- 200 Pages
Global
From €7027EUR$7,950USD£6,089GBP
- Drug Pipelines
- June 2025
- 150 Pages
Global
From €3315EUR$3,750USD£2,872GBP
- Report
- May 2025
- 114 Pages
Global
From €4199EUR$4,750USD£3,638GBP
- Report
- March 2026
- 200 Pages
Global
From €2465EUR$2,789USD£2,136GBP
- Report
- July 2025
- 350 Pages
Global
From €4375EUR$4,949USD£3,790GBP
- Report
- July 2025
- 350 Pages
Global
From €4375EUR$4,949USD£3,790GBP
- Report
- June 2025
- 200 Pages
Global
From €2465EUR$2,789USD£2,136GBP
- Report
- June 2025
- 200 Pages
Global
From €2465EUR$2,789USD£2,136GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2465EUR$2,789USD£2,136GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2465EUR$2,789USD£2,136GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2465EUR$2,789USD£2,136GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2465EUR$2,789USD£2,136GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more